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The in vivo formation of an opioid peptide (exorphin) derived from p-casein has been proved for the first 
time. It was isolated from duodenal thyme of minipigs after feeding with the milk protein casein. The 
exorphin has been identified as a /?-casein fragment by end-group determinations and qualitative amino acid 
analysis of the purified peptide. This peptide, named /I-casomorphin-l l, displayed substantial opioid activity 
in an opiate receptor-binding assay. 
Exorphin Casomorphin @Casein 
1. INTRODUCTION 
The existence of opioid peptides has been de- 
scribed in partial enzymatic digests of proteins 
derived from foodstuffs [l-3]. These peptides are 
called exorphins because of their exogenous origin 
and morphine-like activities. 
Such opioid peptides have been discovered re- 
cently in enzymatic digests of whole bovine casein 
and were designated as Bcasomorphins because 
their sequences identified them as fragments of 
bovine fl-casein [4]. 
The physiological role of casomorphins and 
other exorphins is not yet understood. Neverthe- 
less, evidence exists that exorphins do affect in- 
testinal motility as well as the release of insulin and 
glucagon [5-S]. 
This paper reports on the isolation and charac- 
terization of an opioid peptide from duodenal 
thyme of minipigs after feeding with casein. 
2. MATERIALS AND METHODS 
2.1. Collection and extraction of digesta 
Two male adult G~ttingen minipigs (35 kg) fit- 
ted with T-shaped canulas at the duodenum, 20 cm 
from the pylorus, were fed with 100 g acid-pre- 
(Duodenal digest) Opioid activity 
cipitated casein (Biogen-~asein, Bayr. Milchver- 
sorgung, N~rnberg) after overnight fasting. Post- 
prandial duodenum samples were taken for 8 h, 
frozen immediately in liquid nitrogen and freeze- 
dried. A control experiment was performed after 
feeding with a maize starch diet composed as in [9] 
without casein. 
The extraction of 110 g freeze-dried duodenal 
thyme from 5 collection periods with chloroform/ 
methanol (65 : 35, v/v), and the following batchwise 
adsorption/desorption procedure was performed 
as in [I]. The oily residue from the last desorption 
step was diluted up to 5 ml with methanol. 
2.2. Thin-layer analyses and preparative 
separations 
Aliquots (1 ~1) of the extraction residue were 
subjected to the fingerprint technique on silica gel 
60 sheets (20 x 20 cm, 0.2 mm, Merck). First, elec- 
trophoresis was carried out in pyridine/acetic 
acid/water (100:4:900, by vol.), pH 6.5, at 10 mA 
for 1 h. The second dimension was ascending 
chromatography in chloroform/methanol/2O~o 
ammonia (60: 30: 5, by vol). The peptides were 
detected by a tyrosine-specific spray reagent ac- 
cording to [lo] or by spraying with 0.05% fluores- 
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camine (Serva) in acetone, All ~-casomorphin 
standards were obtained from Sigma. 
The conditions for preparative dectrophoresis 
were the same as for fingerprinting but the sample 
was applied as a streak (80&‘12 cm). Aliquots (12 
pi/17 cm) of the material from several electro- 
phoretic separations were applied to silica ge1 60 
HPLC plates with ~uorescent indicator (10 x 10 
cm, Merck) which had been activated at 100°C for 
1 h. After development in the solvent system as 
described above the main peptide band was visual- 
ized under UV light (254 nm), eluted with chloro- 
form/methanol (1: 1, v/v), evaporated to dryness 
and redissolved in a small volume of methanol. 
The peptide concentration was determined spec- 
trophotometrically with 0.5 ml of an o-phthaldial- 
dehyde @PA, Serva) reagent as in [l l] using L- 
leucine and &casomorphin-7 as standards (J&O = 
6000 M-’ . cm-’ for calculations). 
The purified peptide (2-3 nmol, based upon 
OPA spectrophotometric assay) was first hydro- 
lyzed in 6 M HCI for 18 h at 105’C; the released 
amino acids were dansylated and identified as 
described below. 
A solution of the purified peptide (0.5-i nmol) 
was dried in vacua and the dansyiation carried out 
using 3 ~1 dansyl chloride (Merck) solution in 
acetonitrile and 6 ~1 lithium carbonate buffer, pH 
9.5 [12]. After reaction for 30 min at 30°C an ali- 
quot (OS ~1) was withdrawn to check the purity by 
thin-layer chromatography (TLC). Acid hydrolysis 
and identification of the N-terminal dansyl amino 
acid by two-Dimensions TLC on 5 x 5 cm micro- 
polyamide sheets (Schleicher & Schiill) was carried 
out as in 1131. 
2.5. C-terminal amino acid analysis 
The purified peptide (3-5 nmol) was dissolved in 
60~1 sodium acetate, pH 5.5, buffer, and after ad- 
dition of 0.5 pg carboxypeptidase Y (Sigma) in- 
cubated at 37°C. Timed aiiquots (10 pl) were 
removed and immediately heated for 3 min in a 
boiling water bath. Dansylation and identification 
of the liberated C-terminal amino acid was per- 
formed as described above. 
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2.6. Opiate receptor-binding assay 
Opiate receptor binding in rat brain membrane 
preparations was assayed by competition with ( - )- 
D-13H]naloxone (Amersham, 51 Ci/mmol) ac- 
cording to [14]). The membranes from brains, 
without cerebellum, of 3 male rats (Wistar) were 
reconstituted in 30 ml of 0.05 M Tris-HCI buffer, 
pH 7.4, at 37°C. 
Protein concentration was determined by a 
microprotein assay with the Coomassie G-250 
reagent as in [15] using bovine serum albumin as 
standard. Aliquots (200/1rl) of the membrane pre- 
paration were incubated for 5 min at 37”C, pH 
7.4, with peptides (I-20 nmol), and the incubation 
continued for 15 min after the addition of [3H]- 
naloxone (0.55 pmol, 25 000 cpm) in a final volume 
of 0.5 ml. After rapid filtration through glass fiber 
circles (Whatman, 2.4 cm) and washing with four 
5-ml portions of ice-cold Tris buffer, the filters 
were transferred into counting vials, immersed in 1 
ml TS-1 tissue solubilizer (Zinsser) and kept over- 
night at room temperature. The filters were ex- 
tracted by shaking with 15 ml Ready-SoIv MP 
(Beckman) for 1 h. The radioactivity was counted 
at 40% efficiency after addition of 100 ~1 acetic 
acid/water (1: 1, v/v) and equilibration at $*C in 
a liquid scintillation spectrometer (Packard Tri- 
Carb 2660). Nonspecific binding was determined 
in the presence of a large excess (1 ~mol/l) of 
unlabelled naloxone (Sigma). 
3. RESULTS 
3.1. Purification 
The peptide map of the duodenal extract displays 
at least 23 tyrosine-containing peptides (fig. 1). No 
tyrosine-containing peptides were detectable in the 
duodenal extract after feeding with a protein-free 
diet. 
After preparative electrophoresis the main band 
including the positions of standard P-casomor- 
phin-7 and -5 (1. dim. in fig.1) was eluted. With 
HPLC of the electrophoretically prepurified sam- 
ple on silica gel a more refined preparative separa- 
tion of the hydrophobic peptides (Rr>0.4) was 
achieved (fig.2). The detection with ~uorescamine 
(not shown) revealed that the bulk of interfering 
peptides emerged with & values less than 0.35. 
The application of the tyrosine-specific reagent 
gave 14 peptides with the main band in the position 
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Fig.1. Fingerprint of the tyrosine-containing peptides from duodenal thyme extract on silica gel. Synthetic caso- 
morphins were applied as standards. 1. dim., electrophor~is; 2. dim., ascending chromatography. For detaiis see 
section 2.2. 
of ,&casomorphin-5 (RF 0.42) and two minor 
bands corresponding to P-casomorphin-7 (RF 0.63) 
and ,&casomorphin-4 amide (RF 0.88), The main 
peptide band as indicated by an arrow in fig.2 was 
eluted from several HPLC plates for further char- 
acterization. After rechromatography, the eluted 
peptide (77 nmol) was homogeneous as proved 
after dansylation and by two-dimensional TLC on 
micropolyamide layer. 
3.2. Characterization and opioid activity 
Because of the small quantities of the purified 
peptide the hydrolysed sample was dansylated and 
analysed for qualitative amino acid composition 
by TLC. The constituents found were Pro, Tyr, 
Phe, Gly, Ile, Leu, Asx, Ser. When subjected to N- 
terminal group analysis by the dansyl chloride 
method it revealed tyrosine as the N-terminus. 
In preliminary experiments it was found that the 
experimental conditions for C-terminal analysis 
enabled the slow sequential release of the first 3 
amino acids from synthetic P-casomorphin-5 and 
-7. By treatment of the purified peptide with car- 
boxypeptidase Y for 30 min only leucine was 
released and consequently recognized as the C- 
terminus. 
As the purified peptide had been isolated from 
a duodenal digest of bovine casein, the sequences 
of as-, ,& and x-casein were examined for regions 
containing the determined end-groups and amino 
acid residues. It was indeed discovered that the 
composition found is only compatible with a frag- 
ment of ,&casein (genetic variant A2 or A3) 1161 
originating at Tyr 60 and extending to Leu 70: Tyr- 
Pro-Phe-Pro-Gly-Pro-Be-Pro-Asn-Ser-Leu. 
Our results allow the conclusion that the purified 
peptide contains the whole P-casomorphin-7 se- 
quence (N-terminal) plus the next 4 amino acids in 
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Fig.2. Thin-layer chromatogramm of the electrophoreti- 
tally prepurified sample from duodenal thyme extract. 
Synthetic casomorphins were applied for comparison. 
For details see section 2.2. 
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Fig.3. Displacement of specifically bound [3H]naloxone 
from particulate fractions of rat brain homogenates by
,&casomorphin-1  in comparison to synthetic P-caso- 
morphin-5. The incubation volume (0.5 ml) contained 
0.7 mg protein, 1.1 nmol/l [3H]naloxone and the 
indicated concentrations of casomorphins. Control 
specific binding was 1806 cpm (77% of the total bound). 
,&Casomorphins are hidden in an inactive state 
inside the casein structure. To exert biological ef- 
fects in vivo, they must be produced in the in- 
testinal tract but resist complete degradation by in- 
testinal proteases. Because of the known specificity 
of pepsin and pancreatic peptidases, cleavage of 
peptide bonds releasing significant amounts of ,& 
casomorphins from the corresponding @casein se- 
quence is unexpected. Furthermore, the proline- 
rich fi-casomorphin structure itself was described 
as being highly resistant towards proteolysis by 
gastric and pancreatic enzymes [4,17]. However, 
the intestinal brush border contains high levels of 
peptidase activity [19], so that the action of several 
peptidases from the intestinal epithelium could 
contribute to the rise of free casomorphins. 
Authors in [20] and [21] have shown that the in 
vitro digestion of buffalo ,&casein released neither 
fi-casomorphin-7 nor a fragment of it but a 
putative precursor (decapeptide) which was further 
digested by incubation with brush border pep- 
tidases, especially with dipeptidyl peptides IV from 
human intestine; the peptides were not checked for 
their opioid activities. 
The question arises as to whether the isolated ,& 
casomorphin-1  may be considered as a precursor 
for smaller casomorphin fragments, because two 
further peptides from duodenal thyme have indeed 
shown a chromatographic behaviour correspond- 
ing to standard ,&casomorphin-7 and -4 amide, 
respectively (fig.2). 
Values are means of 3 separate determinations. It seems likely that fl-casomorphin-1  itself can 
the sequence of &casein. Moreover, it displayed 
opioid activity in an opiate receptor-binding assay 
(fig.3) and hence was referred to as fi-casomor- 
phin-Il. As shown in fig.3, the isolated p-caso- 
morphin-ll exhibited a weaker but substantial 
(micromolar) affinity for opiate receptors as com- 
pared with synthetic fl-casomorphin-5 which is 
known to be a very potent opioid peptide in several 
bioassays [17,18]. 
4. DISCUSSION 
The present results show that a peptide with 
opioid activity, termed &casomorphin-1 1, can be 
isolated in vivo from duodenal thyme of minipigs 
after feeding with casein whereas no casomorphin- 
like peptides could be detected after a casein meal 
in the gastric thyme (H. Meisel, unpublished). 
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interact with receptors in the intestinal tract, or 
may be degraded to further opioid fragments in the 
brush border. Such highly hydrophobic fragments 
are expected to be absorbed into the bloodstream 
and to bind to brain opiate receptors as well as to 
those of peripheral organs [2,3]. Both rapid brush 
border degradation and high absorption rate could 
be possible explanatations for the relatively low 
amounts of ,&casomorphin-I 1 found in duodenal 
thyme (77 nmol isolated vs about 1.0 mmol in- 
gested). 
In the present study the formation of an opioid 
peptide has been proved for the first time in vivo, 
and under physiological conditions. however, it is 
not yet clear whether the opioid @-casomorphins 
could reach concentrations of physiological signi- 
ficance. Thus, their possible 
ficance has to be elucidated 
studies. 
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